AXGN Axogen Inc
Price (delayed)
$17.69
Market cap
$784.44M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$0.23
Enterprise value
$821.97M
Axogen (AXGN) is the leading company focused specifically on the science, development, and commercialization of technologies for peripheral nerve regeneration and repair. Axogen employees are passionate about helping to restore
Highlights
The company's EPS has surged by 55% YoY and by 28% QoQ
Axogen's net income has surged by 54% YoY and by 30% QoQ
Axogen's quick ratio has decreased by 13% from the previous quarter
Key stats
What are the main financial stats of AXGN
Market
Valuations
Earnings
Shares outstanding
44.34M
Market cap
$784.44M
Enterprise value
$821.97M
Price to earnings (P/E)
N/A
Price to book (P/B)
7.49
Price to sales (P/S)
4.18
EV/EBIT
N/A
EV/EBITDA
135.22
EV/Sales
4.39
Revenue
$187.34M
Gross profit
$141.98M
Operating income
-$3.29M
Net income
-$9.96M
EBIT
-$1.76M
EBITDA
$6.08M
Free cash flow
$1.43M
Per share
Balance sheet
Liquidity
EPS
-$0.23
EPS diluted
-$0.23
Free cash flow per share
$0.03
Book value per share
$2.36
Revenue per share
$4.23
TBVPS
$4.48
Total assets
$203.73M
Total liabilities
$99.82M
Debt
$71.09M
Equity
$103.91M
Working capital
$68.61M
Debt to equity
0.68
Current ratio
3.24
Quick ratio
2.08
Net debt/EBITDA
6.17
Margins
Efficiency
Dividend
EBITDA margin
3.2%
Gross margin
75.8%
Net margin
-5.3%
Operating margin
-1.8%
Return on assets
-5.2%
Return on equity
-10.2%
Return on invested capital
-0.8%
Return on capital employed
-1%
Return on sales
-0.9%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
AXGN stock price
How has the Axogen stock price performed over time
Intraday
-0.67%
1 week
-5.9%
1 month
-11.59%
1 year
126.5%
YTD
7.34%
QTD
-4.38%
Financial performance
How have Axogen's revenue and profit performed over time
Revenue
$187.34M
Gross profit
$141.98M
Operating income
-$3.29M
Net income
-$9.96M
Gross margin
75.8%
Net margin
-5.3%
AXGN's operating margin has soared by 87% YoY and by 62% QoQ
Axogen's operating income has soared by 85% YoY and by 61% from the previous quarter
The company's net margin has surged by 61% YoY and by 33% QoQ
Axogen's net income has surged by 54% YoY and by 30% QoQ
Growth
What is Axogen's growth rate over time
Valuation
What is Axogen stock price valuation
P/E
N/A
P/B
7.49
P/S
4.18
EV/EBIT
N/A
EV/EBITDA
135.22
EV/Sales
4.39
The company's EPS has surged by 55% YoY and by 28% QoQ
AXGN's P/B is 68% above its 5-year quarterly average of 4.5 and 48% above its last 4 quarters average of 5.1
The equity has increased by 9% YoY and by 4.5% QoQ
AXGN's P/S is 50% above its last 4 quarters average of 2.8 and 17% above its 5-year quarterly average of 3.6
The revenue has grown by 18% YoY and by 3.6% from the previous quarter
Efficiency
How efficient is Axogen business performance
The company's return on sales has surged by 92% YoY and by 74% QoQ
Axogen's return on invested capital has surged by 91% YoY and by 72% QoQ
The ROA has soared by 54% YoY and by 31% from the previous quarter
Axogen's ROE has soared by 54% YoY and by 32% from the previous quarter
Dividends
What is AXGN's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for AXGN.
Financial health
How did Axogen financials performed over time
The total assets is 104% higher than the total liabilities
Axogen's quick ratio has decreased by 13% from the previous quarter
AXGN's current ratio is down by 13% since the previous quarter but it is up by 12% year-on-year
The company's debt is 32% lower than its equity
The debt to equity has contracted by 11% YoY and by 6% from the previous quarter
The equity has increased by 9% YoY and by 4.5% QoQ
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.